Health Innovations

Health Innovations, founded in 2007 and based in Utrecht, Netherlands, is a venture capital firm dedicated to investing in companies that provide practical solutions in healthcare. The firm focuses on various sectors, including digital health, eHealth, medical technology, and health services, targeting both seed and growth-stage companies. By leveraging their knowledge, experience, and network, Health Innovations aims to create value for healthcare, entrepreneurs, and shareholders. Their investment strategy is centered on supporting innovations that enhance prevention, diagnosis, treatment, and monitoring within the healthcare landscape, while maintaining an active role as shareholders without assuming the responsibilities of entrepreneurs.

Jan Willem Kuenen

Impact Venture Partner

Yvonne Sijm

Investment Manager

8 past transactions

AskDr

Acquisition in 2023
AskDr is a health information platform designed to enhance public access to reliable health information by connecting users with verified doctors. The platform features a comprehensive knowledge bank that offers free, credible information to patients. It aims to improve visibility for healthcare professionals while integrating an ecosystem that links healthcare providers with patients. This enables users to receive personalized recommendations, research existing content, and access trustworthy healthcare information, ultimately fostering informed health decisions.

Aiosyn

Seed Round in 2022
Aiosyn is a company focused on enhancing diagnostic precision in cancer and chronic kidney diseases through the development of artificial intelligence-driven pathology algorithms. Utilizing a modular software-as-a-service model, Aiosyn integrates its algorithms with existing pathology workflows, thereby streamlining processes for healthcare professionals. The company's platform promotes collaboration between pathologists and AI, facilitating improved decision-making in both clinical diagnostics and drug development. By improving the efficiency of studies for biopharmaceutical companies, Aiosyn aims to enhance the accuracy of diagnoses and ultimately increase the survival rates of patients with cancer and chronic kidney diseases.

Prolira BV

Venture Round in 2022
Prolira BV is a Dutch company based in Utrecht that specializes in developing medical technology for the early detection of delirium, an acute brain failure condition. Founded in 2015, Prolira has introduced DeltaScan, an EEG-based device designed to monitor brain activity and facilitate timely treatment for patients at risk of acute encephalopathy and delirium. The DeltaScan system comprises a single-use electrode patch, known as the DeltaScan Patch, and the DeltaScan Monitor, which employs a validated proprietary algorithm to analyze EEG data. This innovative approach aims to enhance patient recovery by supporting clinicians in identifying and addressing delirium, a condition that affects approximately 20 million patients annually in hospitals across Europe and the United States, leading to significant cognitive impairment and increased healthcare costs.

Bilihome B.V.

Seed Round in 2022
Bilihome aims to provide an ordinary-looking romper or vest for newborns, which enables natural care and free bonding during jaundice therapy in the first week of life. The embedded smart wearables and the miniaturized system simplify the logistics and encourage care outside the hospital.

ViCentra

Series C in 2021
ViCentra B.V., based in Utrecht, the Netherlands, specializes in the development of medical devices, particularly for diabetes management. The company focuses on creating user-friendly and aesthetically pleasing products that aim to enhance the overall experience for individuals managing their health. ViCentra emphasizes the importance of excellent customer experiences and approaches product design with the belief that simplicity and effectiveness lead to better health outcomes. In addition to its operations in the Netherlands, ViCentra also has a presence in the UK, where it continues to innovate in the field of medical devices through dedicated research and development efforts.

ViCentra

Venture Round in 2020
ViCentra B.V., based in Utrecht, the Netherlands, specializes in the development of medical devices, particularly for diabetes management. The company focuses on creating user-friendly and aesthetically pleasing products that aim to enhance the overall experience for individuals managing their health. ViCentra emphasizes the importance of excellent customer experiences and approaches product design with the belief that simplicity and effectiveness lead to better health outcomes. In addition to its operations in the Netherlands, ViCentra also has a presence in the UK, where it continues to innovate in the field of medical devices through dedicated research and development efforts.

Shleep

Seed Round in 2019
Shleep B.V. is a digital sleep coaching platform based in Amsterdam, Netherlands, founded in 2016. It focuses on addressing sleep-related issues for employees, teams, and leaders by offering a range of services designed to enhance sleep quality and manage sleep deprivation. The platform features personalized sleep programs, assessments, and a variety of resources, including exercises, coaching modules, relaxation tools, and consultations. Users benefit from a unique algorithm that tailors advice to their specific situations. Shleep also conducts live webinars and workshops, fostering a cultural change around the importance of sleep in workplace performance. The company serves clients from various sectors, including consultancies, technology firms, and banks, utilizing an online platform, an HR dashboard, and a mobile application to deliver its services.

DEARHealth

Series A in 2019
DEARhealth, Inc. is a health technology company based in Beverly Hills, California, that specializes in developing a software-as-a-service (SaaS) healthcare management platform tailored for medical providers and health insurers. Founded in 2013, the company focuses on value-based healthcare solutions aimed at enhancing the health outcomes and experiences of chronically ill patients while simultaneously reducing associated costs. Utilizing advanced data analytics, DEARhealth's platform facilitates coordinated care pathways, streamlines provider workflows, and supports organizational decision-making. The technology is specifically designed for the management of complex and costly diseases, enabling healthcare professionals to optimize care and improve measurable patient outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.